Faculty

PHARMACEUTICAL CHEMISTRY

Dr K. Nagarajan is a Professor and Principal in the Department of Pharmaceutical Chemistry, KIET School of Pharmacy, KIET Group of institutions, Delhi-NCR, Ghaziabad and he is Dynamic, Multifaceted, Quick Learner and One of the Responsible Leader of the Department having 21 years of affluent Teaching, Research and Industrial experience. He has completed his Ph. D in Pharmacy from Jadavpur University, Kolkata in 2010; M. Pharm (Pharmaceutical Chemistry) from Birla Institute of Technology, Ranchi in 2001; B. Pharm from Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore affiliated to The Tamilnadu Dr. M. G. R. Medical University, Chennai in 1998. Selected for a Colonel Fairleigh S. Dickinson International Scholarship of U.S $ 5000 for the 2005-2006 academic year in recognition of candidate’s potential and past educational achievements. Selected as Fellow of Institution of Chemists (India) (F.I.C) as Honorary Life Fellowship since 2020. Served as Scientist in MCD-Drug Discovery Department, Torrent Research Centre, Gandhi Nagar for a short stint in 2001. Qualified GATE’99 with 93.33 percentile having All India Rank of 190. Published 115 research papers in Journal of Repute, out of which 41 Scopus and 15 SCI indexed which includes 37 National and 78 International Journals, presented 65 papers which includes 47 National and 18 International Conferences, authored 10 Books, holds 4 Indian Patents, delivered 17 Guest lectures, organized 11 events, completed 2 Expert trainer program & 13 MOOCs courses, participated in 16 continuous education learning programs, so far. Received 4 Grants with a cumulative worth of 38.00647 Lacs from Funding Bodies such as AICTE & AKTU. He is Life member of Various Professional Bodies like APTI, IPA, ISTE, SOPI, CSI, IFERP, The Indian Pharmacists Association. Awarded with CV Raman Award consecutively for the session 2017-18, 2018-19 and 2019-20 as Best Researcher by KIET Group of Institutions. Received KIET’s Best Faculty Incentive in

                  

• Dr. K. Nagarajan (2019-20 ). Recent updates on Antiviral drug design against COVID-19 using suitable enzyme targets. International Journal of Pharmaceutical Sciences Review and Research. ISSN:0976-044X
• Dr. K. Nagarajan (2019-20). An Insight for Potent In-Vitro Antioxidant Status of Short-Chain Peptides. International Journal of Peptide Research and Therapeutics. ISSN:1573-3149
• Kandasamy Nagarajan (2017-18). Antimicrobial Peptidomimetics for Recurrent Septicemia Infections: In Vitro Study for Immuno Compromised Disease Target. Drug Research. ISSN:0019462X
• Kandasamy Nagarajan (2016-17). Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a University Hospital in New Delhi. Korean Journal of Internal Medicine. ISSN:1226-3303 
• K.Nagarajan, Parul Grover, Roma Ghai (2016-17). Anti-nociceptive effect of some synthesized smaller chain tripeptides and tetrapeptides in mice. Medicinal Chemistry Research. ISSN:1054-2523
• Kandasamy Nagarajan (2015-16). Lycopene potentiates the protective effect of Aliskiren on Doxorubicin- induced cardiomyopathy in rats. Journal of Pharmacy and Nutrition Sciences . ISSN:19275951
• K. Nagarajan (2022-23). Design of small chain peptides as inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase. Pharmacologyonline. ISSN:1827-8620
• K. Nagarajan (2022-23). Evaluation of Invitro antioxidant potency of Arnebia nobilis root extract. Pharmacologyonline. ISSN:1827-8620
• K. Nagarajan (2022-23). Analytical method development and validation parameters of drug Ivermectin. International Journal of Life Science and Pharma Research. ISSN:2250-0480
• K.Nagarajan (2022-23). Insilco screening and synthesis of tripeptides for tuberculosis. Europian Chemical Bulletin. ISSN:20635346

• K. NAGARAJAN. Drug designing of peptidomimetics as antitubercular agent for the invitro predictive binding to P-gl. International Conference on Drug Design 2017. ISBN:NA
• K. NAGARAJAN. Invitro cardioprotective antioxidant activity of Peptides with the prediction of IC50 values. International Conference on Frontiers in Science & Technology(ICFST-17). ISBN:
• K. NAGARAJAN. Invitro antioxidant activity of Synthesized Peptidomimetics using the calculation of IC50 values. International Conference on Frontiers in Science & Technology(ICFST-17). ISBN:
• K. NAGARAJAN. Invitro antioxidant activity of the smaller chain peptides against DHODase enzyme target of Malaria. International Conference on Frontiers in Science & Technology(ICFST-17). ISBN:
• K. NAGARAJAN. Lipinski drug filters and Molinspiration for the shorter chain peptides: Identification of potent he. International Conference on Frontiers in Science & Technology(ICFST-17. ISBN:
• K. NAGARAJAN. Antioxidant activity of designed peptidomimetics based on fullerene-C60 scaffold shorter chain dipep. IHPA HEALTHCON 51st Annual Conference. ISBN:
• K. NAGARAJAN. Boman index, Drug like filters and Molecular dynamics as a tool in rational drug design: Application. Recent Advances in Computational Drug design. ISBN:

• K. NAGARAJAN (2014-11-30). Glycopeptides and their medicinal potency as antioxidants. Scholars Press. ISBN:978-3-659-84305-1
• K. NAGARAJAN (2014-05-31). Glutamic acid as antineoplastic agent-A Synthetic and Biological approach. Lambert Academic Publishing. ISBN:978-3-659-64012-4
• K. NAGARAJAN (2011-05-31). Basic Principles of Radioassays. Lambert Academic Publishing. ISBN:9783660000000
• K. NAGARAJAN (2019-01-07). Trends in Hyphenated Analytical Techniques. Lambert Academic Publishing. ISBN:9783840000000
• K. NAGARAJAN (2017-07-01). Fundamental Principles of Drug Discovery. Lambert Academic Publishers. ISBN:978-613-9-98144-1

• Dr. K. Nagarajan, Ms. Parul Grover, Ms. Mayuri Mishra, Dr. Vinay Kumar (2017-08-18). Design, Synthesis & Aminoacid Composition of Fullerene Based Peptidomimetics Against Leukemia And Ovarian Cancer. Indian Patent Office. Application Number:201611004953 A
• Dr. K. Nagarajan, Dr. Parul Grover, Dr. Roma Ghai, Ms. Garima Varshney (2019-06-14). Novel Peptidomimetics Lead as Potent Hepatoprotective Agent. Indian Patent Office. Application Number:201911021626 A
• Dr. Ashu Mittal, Dr. Alankar  Srivastava, Dr. K Nagarajan (2020-11-06). A HPLC -MS Method For Estimation Of Lopinavir And Ritonavir In Human Plasma Using Fluxetine  . Indian Patent Office. Application Number:202011045306 A
• KIET, Dr. Richa Goel, Dr. K. Nagarajan (1900-01-00). Refrigeration Unit with Independent Temperature Control Multiple Compartments space. Indian Patent Office. Application Number:360128-001
• Dr. Abhishek Kumar, Priya Bansal, Dr. N.G. Raghavendra Rao, Dr. Kandasamy Nagarajan, Piyush Mishra, Bharti Bhatiya, Prateek Tiwari, Irfan Ali (2023-01-06). METHOD FOR DEVELOPING SKIN CARCINOMA TO SCREEN AN ANTICANCER DRUG. Indian Patent Office. Application Number:202211056238 A
• Dr. K. Nagarajan, Ms. Vidhu Saxena (2022-02-25). Secure Decentralized Healthcare system for India. Indian Patent Office. Application Number:202211008326
• Dr. Abhay Bhardwaj, Mr. Anuj Pathak, Dr. K Nagarajan (1900-01-00). A ROOM ENVIRONMENTAL CONDITION MONITORING DEVICE. Indian Patent Office. Application Number:370996-001
• Dr. K. Nagarajan, Dr. Vibhav Kumar Sachan, Dr.Parul Grover, Dr.Roma Ghai, Dr.Garima Kapoor, Ms.Richa Goel, Ms.Ranjana Ranjan (2020-06-26). Antithrombotic And Antihypertensive Peptides. Indian Patent Office. Application Number:202011020473 A

• AKTU, Lucknow(2), Amity University, Noida (1)
• Sridhar University, Pillani (1)
• Sridhar University, Pilani (1) AKTU (2) Amity University, Noida(1) Bansathali Vidyapith(1)
• Sridhar University, Pilani (1) AKTU (2) Amity University, Noida(1) Bansathali Vidyapith(1)

• Dr. K. Nagarajan (2019-20). Design & Development of fullerene based novel peptide scaffolds as potent antitubercular agents. All India Council for Technical Education (AICTE)-RPS. Amount:22.17

Email Id: k.nagarajan@kiet.edu

https://www.linkedin.com/in/k-nagarajan-90a99a136/